Fundz

Arvinas, Inc. reported raising $32.5 Million in an initial SEC Form D filing, from an offering of $32.5 Million

PUBLIC · ARVNJul 21, 2019

Amount Raised

$32.5 Million

$32.5 Million sold, per SEC Form D (first sale Jul 21, 2019)

Round Type

Venture

New HavenBiotechnologyHealth CareTherapeuticsresearch

Quick answer

Arvinas raised $32.5 Million in a funding round, dated July 21, 2019. Arvinas is based in New Haven, Connecticut, United States.

How much did Arvinas raise?
Arvinas raised $32.5 Million in a funding round on July 21, 2019.
What does Arvinas do?
Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of..
Where is Arvinas based and how big is it?
Arvinas is based in New Haven, Connecticut, United States. Fundz records about 430 employees.
Who are the decision-makers at Arvinas?
Fundz holds 1 contact at Arvinas. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and research around the same time

Companies in the same sectors as Arvinas that raised within 45 days of this round, from Fundz verified event records.

  • MapLight Therapeutics raised $105M on September 4, 2019.
  • Cartesian Therapeutics, Inc. raised $5.8M on September 4, 2019.
  • BNB Plus raised $418K (Seed) on August 27, 2019.
  • Landos Biopharma, Inc. raised $60M on August 23, 2019.
  • Werewolf Therapeutics raised $32M on August 15, 2019.
  • Vaccinex raised $14M on August 14, 2019.

Who to call at Arvinas, and when

A new round usually means Arvinas is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arvinas raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arvinas, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arvinas. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arvinas

Location

5 Science Park

New Haven, Connecticut, United States

About

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs: ARV-766 and bavdegalutamide for the treatment of men with metastatic castration-resistant prostate cancer; and vepdegestrant (ARV-471) for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arvinas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts10 people are listed at Arvinas. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arvinas's next move

See what Strategic adds

Arvinas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.